Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis

Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis

ObjectiveThis study was designed to explore the predictive value of plasma phenylalanine (Phe) and gut microbiota-derived metabolite phenylacetylglutamine (PAGln) in coronary in-stent restenosis (ISR).MethodsPatients with coronary ISR, in-stent hyperplasia (ISH), and in-stent patency (ISP) were retr...

Full description

Bibliographic Details
Main Authors: Yuan Fu, Yixing Yang, Chen Fang, Xinming Liu, Ying Dong, Li Xu, Mulei Chen, Kun Zuo, Lefeng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
in-stent restenosis (ISR)
coronary artery disease (CAD)
gut microbiota (GM)
metabolome
phenylacetylglutamine (PAGln)
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.944155/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.944155/full

Similar Items